tradingkey.logo
tradingkey.logo

Microport Neuroscientific Says FDA Grants Breakthrough Device Designation To Apollo Dream Rapamycin Stent System

ReutersMar 18, 2026 10:30 AM

- MicroPort NeuroScientific Corp 2172.HK:

  • FDA GRANTS BREAKTHROUGH DEVICE DESIGNATION TO APOLLO DREAM RAPAMYCIN STENT SYSTEM

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI